Antihypertensive treatment and homocysteine concentrations

Metabolism: Clinical and Experimental

Volumn 52, Issue 3, 2003, Pages 261-263

  Westphal, Sabine ^a   Rading, Anita ^a   Luley, Claus ^a   Dierkes, Jutta ^a  

^a Institute of Clinical Chemistry   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; CREATININE; CYANOCOBALAMIN; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; HOMOCYSTEINE; HYDROCHLOROTHIAZIDE; PYRIDOXINE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG CHOICE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; FOLIC ACID BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEART PROTECTION; HUMAN; KIDNEY FUNCTION; MALE; NORMAL VALUE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME; TREATMENT PLANNING; VITAMIN BLOOD LEVEL;

EID: 0037354622     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2003.50060     Document Type: Article

References (15)

1. Nygard O, Nordrehaug JE, Refsum H, et al: Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease. 337:230-236, 1997
2. Nygard O, Vollset SE, Refsum H, et al: Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study JAMA 274:1526-1533, 1995
3. Jacques PF, Bostom AG, Wilson PW, et al: Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73:613-621, 2001
4. Dworkin LD: Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens 10:551-553, 2001
5. Vester B, Rasmussen K: High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 29:549-554, 1991
6. Van Guldener C, Stam F, Stehouwer CD: Homocysteine metabolism in renal failure. Kidney Int Suppl 78:S234-237, 2001
7. Joosten E, Lesaffre E, Riezler R: Are different reference intervals for methylmalonic acid and total homocysteine necessary in elderly people? Eur J Haematol 57:222-226, 1996
8. Herrmann W, Schorr H, Geisel J, et al: Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease. Clin Chem Lab Med 39:739-746, 2001
9. Dierkes J, Westphal S, Luley C: Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Lancet 354:219-220, 1999
10. Westphal S, Dierkes J, Luley C: Effects of fenofibrate and gemfibrozil on plasma homocysteine. Lancet 358:39-40, 2001
11. Apeland T, Mansoor MA, Strandjord RE: Antiepileptic drugs as independent predictors of plasma total homocysteine levels. Epilepsy Res 47:27-35, 2001
12. Fored CM, Ejerblad E, Lindblad P, et al: Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 345:1801-1808, 2001
13. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 82:1616-1628, 1990
14. Kezdi P, Kezdi PC, Khamis HJ: Diuretic induced long term hemodynamic changes in hypertension. A retrospective study in a MRFIT clinical center. Clin Exp Hypertens A 14:347-365, 1992
15. Freis ED: The efficacy and safety of diuretics in treating hypertension. Ann Intern Med 122:223-226, 1995